Par Pharmaceutical Inc saidit received approval from the Food and Drug Administration ontwo applications to manufacture and market the generic drugLeucovorin Calcium in tablet form.    Par said it would begin to market the drug in dosagestrengths of five mg and 25 mg.    Leucovorin calcium is the generic name for Wellcovorin, aproduct of &lt;Burroughs Wellcome Co> used as an adjunct to cancertherapy, the company said. Reuter&#3;